Role of Individualized Homoeopathic Treatment for Resolving Atopic Dermatitis: A Case Report
Case Report
Abstract
Atopic dermatitis is a chronic, pruritic skin disorder that affects approximately 20–25% of children, with nearly 35% of cases persisting into adulthood. It is widely prevalent in both developing and developed countries and is commonly associated with individuals who have a predisposition to allergic conditions.
The purpose of this case report is to highlight a case of atopic dermatitis associated with psychological symptoms and to demonstrate the effectiveness of individualized homeopathic treatment based on mental, general, and particular symptoms.
A 35-year-old female patient, diagnosed with atopic dermatitis, presented with eczematous lesions over the neck and hands. The lesions were accompanied by burning sensation, redness, and intense itching. The symptoms were aggravated during nighttime and were temporarily relieved by scratching. The patient had previously used conventional dermatological medications, which provided only temporary and partial relief.
Seeking a long-term solution, the patient opted for homeopathic treatment. A detailed case-taking was conducted, followed by analysis using Materia Medica and repertorization. Based on the totality of symptoms, Mercurius solubilis (Merc sol) 30C was prescribed.
Following treatment, the patient showed marked improvement in all symptoms. The intensity of itching and burning reduced significantly, and the eczematous lesions gradually subsided.
This case suggests that individualized homeopathic treatment, particularly with Merc sol, may be beneficial in managing atopic dermatitis when prescribed according to the totality of symptoms. However, further clinical studies are required to validate its effectiveness and establish broader applicability.
Keywords Atopic dermatitis; individualized homoeoepathic treatment; case report; repertorisation
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Alok Ranjan, Madina Ansari

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.